MALMO, Sweden – Startup Arthro Therapeutics will use $2.2 million in funding to continue developing its flagship product, Joint Academy, a digital evidence-based intervention program for people with osteoarthritis.
“We have shown that we deliver clinical proof and outcomes equivalent to traditional face-to-face treatments, but with half the resources,” said Jakob Dahlberg, CEO and co-founder of Arthro Therapeutics, in a statement.
Joint Academy is a digitized version of the Swedish evidence-based program Better Management of Osteoarthritis, which has been completed by more than 60,000 patients.
By transferring the medical protocol to a digital context and mining BOA data gathered over the years, Arthro created a proprietary treatment addressing people with joint pain.
The clinical outcomes have enabled Arthro to capture 40% of the private health insurance market for osteoarthritis in Sweden, covered by major health plans.
“This is something we have managed to reproduce with hundreds of patients, and with the new round of funding, we will be able to bring our program to thousands of patients,” said Dahlberg. “Medicine transformed into software through data science is something we believe will become ubiquitous in the clinical workflow.